
    
      This study design was chosen to assess the differences between pharmacokinetic (PK) and
      pharmacodynamic (PD) parameters, including postprandial glycemic response, of Humalog +
      recombinant human hyaluronidase PH20 (rHuPH20), Humalog alone, and Humulin-R + rHuPH20 at
      optimal doses following a liquid meal.
    
  